Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. [electronic resource]
Producer: 20200701Description: 961-964 p. digitalISSN:- 1569-8041
- Adult
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Autoantibodies -- therapeutic use
- Betacoronavirus
- COVID-19
- Coronavirus Infections -- complications
- Humans
- Male
- Pandemics
- Pneumonia, Viral -- complications
- Receptors, Interleukin-6 -- antagonists & inhibitors
- Respiratory Insufficiency -- diagnostic imaging
- SARS-CoV-2
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.